ebomi
Colour theme
Sign in
Insider · CIK 0001590102

Mehra Anand

CIK 0001590102 Name as filed on the most recent filing

Filed as Mehra Anand (40)

76 transaction lines · from 40 filings · filed 2013-10-30 to 2024-11-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

57 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-11-19 P, Open-market purchase Aclaris Therapeutics, Inc.ACRS 1,499,999, acquired Open Form 4 filing 0001415889-24-027348
2019-11-15 P, Open-market purchase NextCure, Inc.NXTC 5,512,500, acquired Open Form 4 filing 0001104659-19-065582
2019-11-12 P, Open-market purchase Galera Therapeutics, Inc.GRTX 9,000,000, acquired Open Form 4 filing 0000899243-19-027116
2019-05-13 P, Open-market purchase NextCure, Inc.NXTC 6,000,000, acquired Open Form 4 filing 0001144204-19-026681
2018-10-22 P, Open-market purchase Aclaris Therapeutics, Inc.ACRS 4,000,000, acquired Open Form 4 filing 0001144204-18-055025
2018-09-28 P, Open-market purchase Entasis Therapeutics Holdings Inc.ETTX 5,065,860, acquired Open Form 4 filing 0001209191-18-053539
2018-09-18 P, Open-market purchase Principia Biopharma Inc.PRNB 4,590,000, acquired Open Form 4 filing 0001209191-18-051838
2018-05-30 P, Open-market purchase Iterum Therapeutics plcITRM 6,500,000, acquired Open Form 4 filing 0001144204-18-031803
2017-07-24 S, Open-market sale Spark Therapeutics, Inc.ONCE 4 lines 14,861,993, disposed Open Form 4 filing 0001144204-17-038426
2017-06-21 S, Open-market sale Spark Therapeutics, Inc.ONCE 343,330, disposed Open Form 4 filing 0001144204-17-033672
2017-06-20 S, Open-market sale Spark Therapeutics, Inc.ONCE 66,300, disposed Open Form 4 filing 0001144204-17-033672
2017-03-02 S, Open-market sale Spark Therapeutics, Inc.ONCE 993,028, disposed Open Form 4 filing 0001144204-17-013027
2017-03-01 S, Open-market sale Spark Therapeutics, Inc.ONCE 1,135,725, disposed Open Form 4 filing 0001144204-17-012259
2017-02-28 S, Open-market sale Spark Therapeutics, Inc.ONCE 1,643,315, disposed Open Form 4 filing 0001144204-17-012259
2017-02-27 S, Open-market sale Spark Therapeutics, Inc.ONCE 2,724,988, disposed Open Form 4 filing 0001144204-17-012259
2017-02-17 S, Open-market sale Spark Therapeutics, Inc.ONCE 489,850, disposed Open Form 4 filing 0001144204-17-010436
2017-02-16 S, Open-market sale Spark Therapeutics, Inc.ONCE 188,529, disposed Open Form 4 filing 0001144204-17-009684
2017-02-15 S, Open-market sale Spark Therapeutics, Inc.ONCE 2,048,250, disposed Open Form 4 filing 0001144204-17-009684
2017-02-14 S, Open-market sale Spark Therapeutics, Inc.ONCE 61,769, disposed Open Form 4 filing 0001144204-17-009684
2017-02-09 S, Open-market sale Spark Therapeutics, Inc.ONCE 2,433,960, disposed Open Form 4 filing 0001144204-17-008080
2017-02-07 S, Open-market sale Spark Therapeutics, Inc.ONCE 129,690, disposed Open Form 4 filing 0001144204-17-006569
2017-02-06 S, Open-market sale Spark Therapeutics, Inc.ONCE 65,650, disposed Open Form 4 filing 0001144204-17-006569
2017-02-03 S, Open-market sale Spark Therapeutics, Inc.ONCE 1,452,790, disposed Open Form 4 filing 0001144204-17-006569
2017-01-10 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 21,188,325, disposed Open Form 4 filing 0001144204-17-002042
2016-12-16 S, Open-market sale Spark Therapeutics, Inc.ONCE 2 lines 14,980,813, disposed Open Form 4 filing 0001144204-16-140371
2016-12-15 S, Open-market sale Spark Therapeutics, Inc.ONCE 3,711,079, disposed Open Form 4 filing 0001144204-16-140371
2016-12-13 S, Open-market sale Spark Therapeutics, Inc.ONCE 1,188,023, disposed Open Form 4 filing 0001144204-16-139271
2016-12-09 S, Open-market sale Spark Therapeutics, Inc.ONCE 5 lines 5,571,532, disposed Open Form 4 filing 0001144204-16-139271
2016-10-20 S, Open-market sale Marinus Pharmaceuticals IncMRNS 3 lines 1,042,699, disposed Open Form 4 filing 0001144204-16-129201
2016-08-11 S, Open-market sale Spark Therapeutics, Inc.ONCE 2 lines 1,387,679, disposed Open Form 4 filing 0001144204-16-118759
2016-08-10 S, Open-market sale Spark Therapeutics, Inc.ONCE 414,138, disposed Open Form 4 filing 0001144204-16-118759
2016-08-08 S, Open-market sale Spark Therapeutics, Inc.ONCE 6,047, disposed Open Form 4 filing 0001144204-16-118104
2016-08-04 S, Open-market sale Spark Therapeutics, Inc.ONCE 27,120, disposed Open Form 4 filing 0001144204-16-116981
2016-08-03 S, Open-market sale Spark Therapeutics, Inc.ONCE 276,720, disposed Open Form 4 filing 0001144204-16-116981
2016-08-01 S, Open-market sale Spark Therapeutics, Inc.ONCE 1,360,580, disposed Open Form 4 filing 0001144204-16-116325
2016-05-31 S, Open-market sale Spark Therapeutics, Inc.ONCE 30,000, disposed Open Form 4 filing 0001144204-16-106469
2015-11-27 S, Open-market sale Spark Therapeutics, Inc.ONCE 321,107, disposed Open Form 4 filing 0001144204-15-068658
2015-11-25 S, Open-market sale Spark Therapeutics, Inc.ONCE 1,056,836, disposed Open Form 4 filing 0001144204-15-068658
2015-11-12 S, Open-market sale Spark Therapeutics, Inc.ONCE 64,440, disposed Open Form 4 filing 0001144204-15-064912

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 4
  • Open-market sale 53
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Mehra Anand, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001590102

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.